Moreover, several studies point toward PTP1B serving as a potential therapeutic target in various tumors, such as PCa [179], pancreatic cancer [180], ovarian cancer [181], colon cancer [182] and breast cancer [183]. Here, PTPN1 is linked to posterior cortical atrophy.